Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Press release |
13 April 2015
Intellectual property and trade
GermanyIndia

MSF response to Indian Prime Minister’s visit to Germany and EU India FTA negotiations

A man holds antiretroviral drugs at an activist meeting in Soshanguve, a township outside of Pretoria on April 16, 2015 Photograph by Stefan Heunis
Press release
Press release |
31 March 2015
Tuberculosis
LatviaEuropean Union

As first EU Ministerial meeting on tuberculosis closes, MSF calls on the EU to triple funding for TB R&D

3 min
MSF staff conducts a medical consultation with a female MDR-TB patient at MSF’s Insein Prison clinic, Yangon, Myanmar. Photograph by Aye Pyae Sone
Press release
Press release |
24 March 2015
Tuberculosis
European Union

MSF urges EU Health Commissioner and EU Health Ministers not to skip critical regional Ministerial conference on TB next week

3 min
A patient with TB shows the pills for his treatment in a prison in Donetsk, Ukraine, where MSF is helping to treat patients infected with TB. MSF has been running a TB treatment program within the penitentiary system in Donetsk since 2011. Photograph by Manu Brabo
Press release
Press release |
20 March 2015
Tuberculosis

Leading medical organisations team up to bring new TB treatments to those in need

4 min
Press release |
18 March 2015
Hepatitis C

Indian generic companies should reject Gilead’s controversial hepatitis C ‘Anti-Diversion’ programme

5 min
MSF lab technician working in the lab at the Nhlangano TB ward in Shiselweni, Swaziland. Photograph by Giorgos Moutafis Photograph by Giorgos Moutafis
Press release
Press release |
16 March 2015
Tuberculosis
MozambiqueSouth AfricaEswatini

Multi-drug resistant TB strain in Swaziland not detectable by most advanced rapid diagnostic tests

Metro advertisements for Doctors Without Borders, photos by Drew Angerer Photograph by Drew Angerer
Press release
Press release |
11 March 2015
Intellectual property and trade

MSF statement on the latest round of TPP trade talks in Hawaii this week

3 min
Discussion between team members, amongst which Clinical health officer Kenie Musa, before going in to the high-risk zone. Photograph by Anna Surinyach Photograph by Anna Surinyach
Press release
Press release |
25 February 2015
Tropical & neglected diseases
Liberia

Preliminary Results of the JIKI Clinical Trial to test the Efficacy of Favipiravir in Reducing Mortality in Individuals Infected by Ebola Virus in Guinea

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury